BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Babic I, Sellers D, Else PL, Nealon J, Osborne AL, Pai N, Weston-Green K. Effect of liraglutide on neural and peripheral markers of metabolic function during antipsychotic treatment in rats. J Psychopharmacol 2021;35:284-302. [PMID: 33570012 DOI: 10.1177/0269881120981377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Horska K, Ruda-Kucerova J, Skrede S. GLP-1 agonists: superior for mind and body in antipsychotic-treated patients? Trends Endocrinol Metab 2022;33:628-38. [PMID: 35902330 DOI: 10.1016/j.tem.2022.06.005] [Reference Citation Analysis]
2 Yang L, Cheng J, Shi G, Zhang C, Du Y, Chen L, Qiao H, Chen R, Zhang X. Liraglutide Ameliorates Cerebral Ischemia in Mice via Antipyroptotic Pathways. Neurochem Res. [DOI: 10.1007/s11064-022-03574-4] [Reference Citation Analysis]
3 Kanagali SN, Patil BM, Khanal P, Unger BS. Cyperus rotundus L. reverses the olanzapine-induced weight gain and metabolic changes-outcomes from network and experimental pharmacology. Comput Biol Med 2021;:105035. [PMID: 34802711 DOI: 10.1016/j.compbiomed.2021.105035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li DJ, Yue Q, Liu L, Che KK, Liu XM, Hu CH. Brexpiprazole caused glycolipid metabolic disorder by inhibiting GLP1/GLP1R signaling in rats. Acta Pharmacol Sin 2021;42:1267-79. [PMID: 33976388 DOI: 10.1038/s41401-021-00680-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]